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The Modified McGoon Index does not Predict Mortality
in Infants with Congenital Diaphragmatic Hernia
Brett Weitzel, Gerald Holmes, MD, Rebecca Moran, MD
Abstract
Background: Infants diagnosed with congenital diaphragmatic hernia (CDH) continue to
have a high mortality despite medical advances such as inhaled nitric oxide (iNO), high
frequency ventilation (HFV) and/or extracorporeal membrane oxygenation (ECMO). The
mortality in some studies exceeds 80%. The modified McGoon index (MMI), a ratio of
pulmonary artery size to aortic size has been reported to predict survivability in these infants:
infants with a MMI ≤ 1.3 have an 85% mortality: (Pediatr 2000;105:1106).
Objective: To evaluate the utility of MMI in predicting mortality in our population.
Design/Methods: We performed a retrospective review of all infants with CDH admitted to
the University of New Mexico NICU between January 2000 and November 2002. All
available echocardiograms were reviewed by a single pediatric cardiologist blinded to the
outcome of the infants, and the MMI was calculated (LPA + RPA/ Ao). The following
information was also recorded from each infant’s record: gestational age, birth weight, Apgar
scores, need for cardiopulmonary resuscitation in the delivery room, length of hospital stay,
days of ventilation, use of high frequency ventilation, use of iNO, use of ECMO and survival
to discharge.
Results: Eighteen infants with CDH were admitted; echocardiograms were available for 15.
MMI ranged from .06 to 2.37 in the 15 infants. Seven infants died and 8 survived to
discharge. There was no significant difference in birth weight between groups (lived (L):
3151 ± 203; died (D): 2735 ± 186 grams, mean ± SE), gestational age (L: 38.3 ± .4; D: 38.3 ±
1.1), CPR in delivery room (L: 1/8; D: 3/7). Infants who died had lower 5-minute Apgar
scores (L: 7.1± .5; D: 4.8 ± .7, p< 0.05). A greater number of infants who died received
ECMO. There were no differences between groups in the number of infants on HFV or iNO.
An MMI of ≤ 1.3 did not predict death in our patient population: mortality in patients with an
MMI ≤ 1.3 was 46% (6 of 13 infants), while mortality in patients with MMI ≥ 1.3 was 50%
(1 of 2 infants).
Conclusion: MMI ≤ 1.3 did not predict mortality in our population.
Background
Congenital diaphragmatic hernia (CDH) refers to a developmental abnormality in the
diaphragm that allows abdominal viscera to herniate into the chest during the critical period
of fetal lung development when the bronchi and pulmonary arteries are undergoing
branching. CDH has an incidence of approximately one in 2,500 live births1-3 and is
associated with significant morbidity and mortality rates. Approximately 80% of these
irregularities are found on the left side of the diaphragm. The most common form is the
classic posterolateral, also known as Bochdalek, hernia. CDH occurs in conjunction with
other anomalies 40-50% of the time4. The central nervous system is the most commonly
affected system. Congenital heart malformations are also associated with CDHs, and are the
most important comorbidities when considering prognosis. CDH is also associated with
chromosomal abnormalities, including Turner’s syndrome, and trisomy 13 and 18.
Chromosomal irregularities are also associated, such as Fryn’s Syndrome. Familial
associations have been reported although they are very rare5.

Despite medical advances in treatment methods, including inhaled nitric oxide (iNO), high
frequency oscillation ventilation (HFOV), gentle ventilation with permissive hypercapnea,
delayed surgical repair and extracorporeal oxygenation (ECMO), mortality rates continue to
be high. Some studies have shown mortality rates greater than or equal to 80%6, although
they reflect the outcomes of fetuses with life threatening chromosomal and anatomic
anomalies as well as those with isolated CDH. Commonly quoted survival statistics for
isolated CDH are 80% for those infants who do not require ECMO and 50% for those who
do.
Antenatal diagnosis of CDH has been possible for more than two decades and currently
prenatal ultrasounds are used to diagnosis almost 50% of infants with CDH early in the
pregnancy at 16-24 weeks of gestation. The most common findings on ultrasound are the
presence of the stomach in the left chest, which causes the mediastinum to shift to the right.
Aside from the coexistence of chromosomal abnormalities or congenital malformations, no
antenatal findings have been able to accurately predict death in infants with isolated CDH.
Studies in the 1980’s demonstrated an increased mortality with diagnosis of CDH early in
gestation7,8. But with the advent of high-resolution ultrasonography and growing experience
in the prenatal diagnosis of CDH, earlier diagnosis of less severe disease has become more
common. In the 1990’s additional features seen on antenatal sonograms were proposed as
predictors of CDH severity. The findings that were studied included polyhydramnios9,10,
thoracic stomach bubble11, mediastinal shift9, lung-thoracic transverse area ratio12,13, left
ventricular disproportion before 25 weeks gestation14, right lung area to head circumference
ratio15, contralateral lung area and fetal branch pulmonary artery diameters16. All of these
proposed predictors have failed to be substantiated in other studies.
The establishment of predictors of postnatal morbidity and mortality due to CDH are
important in antenatal counseling and planning of perinatal treatment. These predictors may
also impact perinatal palliative care planning in the case of a lethal lesion. In 2001 Suda et al
proposed the Modified McGoon Index (MMI) as a CDH severity predictor17. The MMI is
calculated as the combined diameter of hilar pulmonary arteries, indexed to the descending
aorta at the level of the diaphragm. Their data showed that the MMI had both a high
sensitivity and specificity for mortality due to CDH. Their findings were corroborated in
2006 by Casaccia et al18, but disputed by Yao et al19 in 2004. In the Suda study, a MMI less
than 1.3 predicted mortality with a sensitivity of 80% and a specificity of 100%17.
Introduction
The aim of our study was to evaluate the utility of the MMI in predicting mortality in our
population. We also sought to determine whether antenatal MMI ratios and other parameters
correlate with postnatal outcome and can be used to stratify CDH into mild and severe cases.
Methods
We performed a retrospective review of all infants with congenital diaphragmatic hernia
admitted to the University of New Mexico Neonatal Intensive Care Unit between January
2000 and November 2002. All available echocardiograms were reviewed by a single
pediatric cardiologist blinded to the outcome of the infants, and the modified McGoon Index
was calculated (LPA + RPA/ Ao). The following information was also recorded from each

infant’s record: gestational age, birth weight, Apgar scores, need for cardiopulmonary
resuscitation in the delivery room, length of hospital stay, days of ventilation, use of high
frequency ventilation, use of iNO, use of ECMO and survival to discharge.
Results
Eighteen infants with CDH were admitted during the 23 months studied; echocardiograms
were available for fifteen. MMI ranged from .06 to 2.37 in the 15 infants. Seven infants died
and 8 survived to discharge. There was no significant difference in birth weight between
groups (survived (S): 3151 ± 203; died (D): 2735 ± 186 grams, mean ± SE), gestational age
(S: 38.3 ± .4; D: 38.3 ± 1.1), or CPR in delivery room (S: 1/8; D: 3/7). Infants who died had
lower 5-minute Apgar scores (S: 7.1± .5; D: 4.8 ± .7, p< 0.05). None of the infants who
survived received ECMO during the study period. There were no differences between groups
in the number of infants on HFV or iNO. An MMI of ≤ 1.3 did not predict death in our
patient population: mortality in patients with an MMI ≤ 1.3 was 46% (6 of 13 infants), while
mortality in patients with MMI ≥ 1.3 was 50% (1 of 2 infants).
Conclusion
This small retrospective study did not support Dr. Suda’s findings of an MMI less than 1.3
predicting mortality17. As others have reported, the need for ECMO negatively impacts
survival. In our study population, one infant had chromosomal derangements. In this infant a
6:12 rearrangement was discovered. This infant was also born premature at 34 weeks
gestation and never underwent surgical repair of the lesion. This infant died at 23 days of life.
There were four additional infants who were not repaired: 2 were premature infants, of which
one had congenital heart disease. Another infant of the unrepaired group experienced cardiopulmonary arrest during ECMO cannulation and the other had extension of a intracranial
hemorrhage on ECMO and was withdrawn from support prior to surgical repair of the hernia.
The limitations of the study include the retrospective nature of the study design. After the
release of the Suda article our institution was eager to determine if this measurement was
applicable in our population and was a means for predicting appropriate candidates for
aggressive management and consideration of ECMO. As CDH is a relatively rare diagnosis
the most appropriate initial investigation was a retrospective review to determine if we
should then proceed with prospective data collection.
In summary, the MMI in our small retrospective review of 15 infants with CDH did not
correlate with mortality. We need to aggressively evaluate methods for antenatal and
immediate post-natal prediction of survival to aid in delivery planning, palliative care plans
when appropriate and prognostication for these critically ill children and their families.
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